Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis...

Area of Science:

• Oncology
• Genomics
• Biotechnology

Background:

• Non-invasive liquid biopsy using cell-free DNA (cfDNA) shows promise for cancer detection.
• Current cfDNA analysis methods are often costly and time-consuming due to diverse analytical techniques.
• Combining cfDNA fragment size and copy number variation (CNV) data could enhance early cancer detection.

Purpose of the Study:

• To investigate combining cfDNA fragment size and CNV data for early colorectal cancer detection.
• To compare enzymatic and bisulfite conversion methods for cfDNA analysis in colorectal cancer.
• To evaluate the utility of chromosome 18 cfDNA fragments for early colorectal cancer detection.

Main Methods:

• cfDNA fragments from chromosome 18 were analyzed using both enzymatic and bisulfite conversion.
• A linear discriminant analysis (LDA) model was trained on 2959 regions using cfDNA fragment counts.
• The model was validated on an independent test set to predict early-stage (I-IIA) colorectal cancer.

Main Results:

• Enzymatically converted libraries achieved 87.5% sensitivity and 92% specificity for early colorectal cancer detection.
• Bisulfite-converted data yielded significantly lower accuracy, with 58.3% sensitivity.
• Enzymatic conversion appears to better preserve the cancer-specific fragmentation patterns in cfDNA.

Conclusions:

• Enzymatic conversion is a superior method for integrating cfDNA fragmentation and methylation data for early colorectal cancer detection.
• This approach offers a promising, potentially more efficient, avenue for non-invasive cancer diagnostics.
• Further research can leverage these findings for improved early detection strategies.